BamSEC and AlphaSense Join Forces
Learn More

Stoke Therapeutics Inc. – Indentures

NASDAQ: STOK    
Share price (3/18/26): $31.02    
Market cap (3/18/26): $1.835 billion
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.3
from S-3ASR 43 pages Stoke Therapeutics, Inc. and , as Trustee Indenture Dated as of ,
12/34/56
EX-4.2
from S-3ASR 7 pages Form of Debt Security
12/34/56
EX-4.2
from 10-K 6 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 as of December 31, 2020, Stoke Therapeutics, Inc. (The “Company,” “We,” or “Our”) Had One Class of Securities Registered Under Section 12 of the Securities Exchange Act of 1934, as Amended (The “Exchange Act”): Our Common Stock
12/34/56
EX-4.3
from S-3 37 pages Stoke Therapeutics, Inc. and , as Trustee Indenture Dated as of ,
12/34/56
EX-4.2
from S-3 6 pages Form of Debt Security
12/34/56
EX-4.3
from DRS 37 pages Stoke Therapeutics, Inc. and , as Trustee Indenture Dated as of ,
12/34/56
EX-4.2
from DRS 6 pages Form of Debt Security
12/34/56
EX-4.2
from 10-K 6 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 as of December 31, 2020, Stoke Therapeutics, Inc. (The “Company,” “We,” or “Our”) Had One Class of Securities Registered Under Section 12 of the Securities Exchange Act of 1934, as Amended (The “Exchange Act”): Our Common Stock
12/34/56
EX-4.3
from S-3ASR 32 pages Stoke Therapeutics, Inc. and , as Trustee Indenture Dated as of ,
12/34/56
EX-4.2
from S-3ASR 5 pages Form of Debt Security
12/34/56
EX-4.1
from 8-K 11 pages Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.2
from 10-K 6 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 as of December 31, 2020, Stoke Therapeutics, Inc. (The “Company,” “We,” or “Our”) Had One Class of Securities Registered Under Section 12 of the Securities Exchange Act of 1934, as Amended (The “Exchange Act”): Our Common Stock
12/34/56
EX-4
from 10-Q 17 pages Registration Rights Agreement
12/34/56
EX-4.4
from S-3 32 pages Stoke Therapeutics, Inc. and , as Trustee Indenture Dated as of ,
12/34/56
EX-4.3
from S-3 5 pages Form of Debt Security
12/34/56
EX-4.3
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 Authorized Capital Stock Our Authorized Capital Stock Consists of 300,000,000 Shares of Common Stock, $0.0001 Par Value Per Share, and 10,000,000 Shares of Undesignated Preferred Stock, $0.0001 Par Value Per Share. Common Stock Dividend Rights
12/34/56
EX-4.4
from S-3 32 pages Stoke Therapeutics, Inc. and , as Trustee Indenture Dated as of ,
12/34/56
EX-4.3
from S-3 5 pages Form of Debt Security
12/34/56
EX-4.3
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 Authorized Capital Stock Our Authorized Capital Stock Consists of 300,000,000 Shares of Common Stock, $0.0001 Par Value Per Share, and 10,000,000 Shares of Undesignated Preferred Stock, $0.0001 Par Value Per Share. Common Stock Dividend Rights
12/34/56
EX-4.1
from S-1/A 2 pages Additional Abbreviations May Also Be Used Though Not in the Above List. for Value Received, Hereby Sell(s), Assign(s) and Transfer(s) Unto Please Insert Social Security or Other Identifying Number of Assignee
12/34/56